West Pharmaceutical Services (WST) FCF Margin (2009 - 2026)
West Pharmaceutical Services (WST) posted quarterly FCF Margin of 9.26% for Q2 2026, down 403.0% year-on-year from 3.06% in Q2 2025, and up 65.81% on a QoQ basis from 5.59% in Q1 2026.
West Pharmaceutical Services (WST) FCF Margin (2009 - 2026) Analysis & Trends
West Pharmaceutical Services (WST) has reported FCF Margin for 18 consecutive years, with 9.26% the latest figure, recorded in Q2 2026.
- Quarterly FCF Margin fell 403.0% year-over-year to 9.26% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 13.13% (up 151.0% YoY) and the FY2025 annual result came in at 15.25%, up 570.0% from the prior year.
- FCF Margin grew to 9.26% in Q2 2026 per WST's latest filing, from 5.59% in the prior quarter.
- Over the last five years, FCF Margin for WST reached as high as 21.74% in Q4 2025 and fell as low as 3.97% in Q1 2024.
- A 5-year average of 12.77% and a median of 12.84% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin plunged 644 bps — and 2025, when it jumped 1036 bps.
- Year by year, FCF Margin stood at 19.18% in 2022, then retreated by 7 bps to 17.81% in 2023, then sank by 36 bps to 11.38% in 2024, then soared by 91 bps to 21.74% in 2025, then slumped by 57 bps to 9.26% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 9.26%, 5.59%, and 21.74% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 20.74% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 37.88% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 11.58% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 4.30% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 36.36% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 9.26% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 8.91% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -13.60% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.56% |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 2.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.26% |
| Mar 31, 2026 | 5.59% |
| Dec 31, 2025 | 21.74% |
| Sep 30, 2025 | 16.64% |
| Jun 30, 2025 | 13.29% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 11.38% |
| Sep 30, 2024 | 13.23% |
| Jun 30, 2024 | 9.23% |
| Mar 31, 2024 | 3.97% |
| Dec 31, 2023 | 17.81% |
| Sep 30, 2023 | 17.97% |
| Jun 30, 2023 | 12.44% |
| Mar 31, 2023 | 7.81% |
| Dec 31, 2022 | 19.18% |
| Sep 30, 2022 | 16.17% |
| Jun 30, 2022 | 13.87% |
| Mar 31, 2022 | 11.86% |
| Dec 31, 2021 | 11.54% |
| Sep 30, 2021 | 17.66% |